Jay Clayton has made a career as a Wall Street lawyer. Now he will become become the financial industry’s top watchdog.
On Wednesday, the Trump transition team named Clayton as their nominee for the next chairman of the Securities & Exchange Commission. If confirmed, he is expected to help usher in a period of deregulation, including rolling back parts of the Dodd-Frank Act.
Clayton is currently a partner with the New York-based law firm Sullivan & Cromwell and has represented some of the biggest names on Wall Street. During the financial crisis, he advised Goldman Sachs when it was receiving TARP bailout funds and a $5 billion investment from Berkshire Hathaway. He also advised Bear Stearns on its shotgun sale to JPMorgan Chase in 2008.
He has helped companies navigate regulatory matters, according to his biography on the law firm’s website, including working with large financial companies to reach settlements with the government over mortgage-related securities claims from the financial crisis.
Much of Clayton’s work has to do with mergers, acquisitions and initial public offerings, and he was involved with Alibaba’s record-breaking public debut, the sale of the Atlanta Hawks NBA team and the British Airways merger with Iberia.
“Jay Clayton is a highly talented expert on many aspects of financial and regulatory law, and he will ensure our financial institutions can thrive and create jobs while playing by the rules at the same time,” said President-elect Trump in prepared remarks.
Full Content: Forbes
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas